Immunome Inc. (IMNM) stock
Close on Nov 13, 2026Market cap $2.13BP/E –Yield –
Immunome statistics
72 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 2, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 4.69
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 416.01
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 46.0%
- 10.8%
- Float
- 106M
- 49M
- Shares Held by Insiders
- 6.45%
- 11.7%
- Shares Held by Institutions
- 103.9%
- 56.4%
Short sellingIndustry
- Short Interest
- 16M
- –
- Short Interest Change
- -6.41%
- -0.80%
- Short % of Float
- 15.2%
- 9.01%
- Short % of Shares Outstanding
- 14.2%
- 6.30%
- Days to Cover
- 12.77
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $30.06
- –
- 52-Week Low
- $16.11
- –
- 20-Day Moving Average
- $18.57
- –
- 50-Day Moving Average
- $20.65
- –
- 200-Day Moving Average
- $22.21
- –
- Average True Range (14)
- $1.25
- –
- Price Change (1 Week)
- 0.32%
- -1.15%
- Price Change (1 Month)
- 7.87%
- -4.87%
- Price Change (3 Months)
- -31.5%
- -21.0%
- Price Change (6 Months)
- -10.1%
- -20.6%
- Price Change (YTD)
- -12.6%
- -23.6%
- Price Change (1 Year)
- 7.69%
- -22.4%
- Price Change (3 Years)
- 134.0%
- -29.5%
- Price Change (5 Years)
- 3.53%
- -77.9%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 1M
- –
- Relative Volume
- 0.74
- 0.70
- Relative Strength Index (14)
- 46.9
- 43.4
- Volatility (1 Year)
- 60.8%
- 80.1%
- Beta (5 Years)
- 1.74
- 1.07
MarginsIndustry
- EBITDA Margin
- -5886.7%
- -27.7%
- FCF Margin
- -5118.9%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -62.5%
- -49.9%
- Return on Assets (ROA)
- -55.8%
- -40.6%
- Return on Capital Employed (ROCE)
- -51.4%
- -37.9%
Financial positionIndustry
- Current Ratio
- 11.66
- 3.30
- Quick Ratio
- 11.27
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- -63.3%
- 6.82%
EfficiencyIndustry
- Asset Turnover
- 0.01
- 0.40
- Revenue Per Employee
- $22.68K
- $429.29K
- Profits Per Employee
- -$1.27M
- -$689.41K
- Employee Count
- 177
- 74
- WACC
- 13.8%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $461.58M
- $17.76M
- Net Cash Per Share
- $4.06
- $0.80
- Equity (Book Value)
- $454.30M
- $53.89M
- Book Value Per Share
- $4.00
- $1.50
- Tangible Book Value
- $454.30M
- $27.13M
- Working Capital
- $436.83M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$9.02M
- -$1.00M
- FCF Per Share
- -$1.81
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -10.5%
- -21.8%
- FCF Yield
- -9.64%
- -9.44%
Scores and fair valueIndustry
- Altman Z-Score
- 21.85
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | IMNM | S&P 500 | Difference | IMNM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +6.8% | -3.0% | +9.8 pts | ||
| 3 months | -29.0% | -2.8% | −26.2 pts | ||
| Year to date | -12.6% | +11.5% | −24.1 pts | ||
| 1 year | +13.7% | +13.5% | +0.2 pts | ||
| 3 years | +127.8% | +77.7% | +50.1 pts | +31.6% | +21.1% |
| 5 years | +3.5% | +72.6% | −69.1 pts | +0.7% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
16M IMNM shares were sold short on Oct 30, 2026, down 6.4% from the previous report, or 15.22% of the shares available to trade. At recent volumes it would take 12.8 days to buy them back. Over the last 20 sessions, 66.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 16,173,694 | -6.4% | 1,266,447 | 12.8 |
| Oct 15, 2026 | 17,281,614 | +3.1% | 1,421,723 | 12.2 |
| Sep 30, 2026 | 16,757,287 | +3.2% | 1,691,367 | 9.9 |
| Sep 15, 2026 | 16,244,557 | +3.9% | 787,598 | 20.6 |
| Aug 31, 2026 | 15,634,596 | -10.1% | 1,236,757 | 12.6 |
| Aug 14, 2026 | 17,392,529 | -3.3% | 1,165,021 | 14.9 |
| Jul 31, 2026 | 17,981,724 | +4.3% | 782,638 | 23.0 |
| Jul 15, 2026 | 17,237,765 | -0.7% | 1,635,317 | 10.5 |
| Jun 30, 2026 | 17,366,167 | -4.3% | 2,139,319 | 8.1 |
| Jun 15, 2026 | 18,148,499 | +7.6% | 1,403,494 | 12.9 |
| May 29, 2026 | 16,863,159 | -4.4% | 1,190,675 | 14.2 |
| May 15, 2026 | 17,630,541 | -5.5% | 878,987 | 20.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?